1. 242PImpact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT). (23rd October 2018) Authors: Olympios, N; Lambertini, M; Calbrix, C; Saint-Ghislain, M; Fontanilles, M; Loeb, A; Leheurteur, M; Demeestere, I; Di Fiore, F; Perdrix, A; Clatot, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular basis of agonist docking in a human GPR103 homology model by site‐directed mutagenesis and structure–activity relationship studies. (5th September 2014) Authors: Neveu, C; Dulin, F; Lefranc, B; Galas, L; Calbrix, C; Bureau, R; Rault, S; Chuquet, J; Boutin, J A; Guilhaudis, L; Ségalas‐Milazzo, I; Vaudry, D; Vaudry, H; Santos, J Sopkova‐de Oliveira; Leprince, J Journal: British journal of pharmacology Issue: Volume 171:Number 19(2014:Oct.) Page Start: 4425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗